Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133961) titled 'Construction of a Postoperative Recurrence Prediction Model for Papillary Thyroid Carcinoma Based on cfDNA Multi-Modal Biomarkers and Random Forest Algorithm: A Multicenter Clinical Study' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Langzhong People's Hospital
Condition:
Papillary Thyroid Carcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-01
Target Sample Size: Observation group:2000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340306
Disclaimer: Curated by HT Synd...